Landscapes / Targets
IDH1
9 drugs act on IDH1, in 24 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs9
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Rigel Pharmaceuticals +1 |
Approved | 30 Apr 2027Phase 4 trial completes | ||
| Next date | 30 Apr 2027 · Phase 4 trial completes | ||||
| Also tested for | High Grade Glioma, Astrocytoma and 14 more | ||||
| Open drug page | |||||
Isocitrate dehydrogenase 1 inhibitor |
Approved | 15 Oct 2027Phase 3 trial completes | |||
| Next date | 15 Oct 2027 · Phase 3 trial completes | ||||
| Also tested for | Leukemia, Myeloid, Acute, Cholangiocarcinoma and 3 more | ||||
| Open drug page | |||||
Isocitrate dehydrogenase 1 Inhibitor; isocitrate dehydrogenase 2 inhibitor |
Approved | 2 May 2033Phase 2 trial completes | |||
| Next date | 2 May 2033 · Phase 2 trial completes | ||||
| Also tested for | Residual or Recurrent Grade 2 IDH Mutant Glioma, Severe Hepatic Impairment and 1 more | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Biliary Carcinoma, Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 3 | 1 Dec 2028Phase 3 trial completes | |||
| Next date | 1 Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Oligodendroglioma, Glioma and 11 more | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Dec 2028Phase 3 trial completes | |||
| Next date | 31 Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Acute Myeloid Leukemia | ||||
| Open drug page | |||||
Olutasidenibnot checked |
— |
Phase 2 | Sep 2030Phase 2 trial completes | ||
| Next date | Sep 2030 · Phase 2 trial completes | ||||
| Open drug page | |||||
— |
Novartis · Public NVS |
Phase 1 | — | ||
| Also tested for | Advanced Malignancies That Harbor IDHR132 Mutations | ||||
| Open drug page | |||||
— |
Eli Lilly · Public LLY |
Phase 1 | — | ||
| Also tested for | Cholangiocarcinoma, Chondrosarcoma and 6 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 8 of 9 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026